Q4 2024 Vext Science Inc Earnings Call Transcript
Key Points
- Vext Science Inc (VEXTF) reported a strong fourth quarter of 2024, with revenue reaching $10.2 million and adjusted EBITDA of $3.2 million, marking the strongest operating quarter in recent years.
- The successful launch of Ohio's adult-use market significantly contributed to revenue growth and increased cash flow, with Ohio's retail locations delivering 40% growth in total sales in Q4 2024.
- For fiscal year 2024, Vext Science Inc (VEXTF) generated revenue of $36 million, a 3% increase over fiscal 2023, and adjusted EBITDA of $9.2 million, up 66% year-over-year.
- The company is well-positioned for future growth in Ohio, with plans to expand to eight retail locations, maximizing its license cap and enhancing its vertically integrated operations.
- Vext Science Inc (VEXTF) has a solid balance sheet with $4.6 million in cash as of December 31, 2024, and does not anticipate any capital raises for operational expenses or Ohio retail expansion plans.
- Arizona's cannabis market faced significant challenges in 2024, with total statewide sales declining 12.6% and average per store sales dropping 25% due to oversupply and heightened competition.
- Despite strong performance in Ohio, Vext Science Inc (VEXTF) experienced pricing pressures in Arizona, impacting overall profitability.
- The company recorded a noncash impairment charge of $2.9 million in Q4 2024 due to the wind down of its Oklahoma joint venture and the Happy Travel's joint operation in California.
- Vext Science Inc (VEXTF) anticipates continued pricing pressure in Arizona due to excess cultivation capacity and a saturated brand landscape.
- The company is facing regulatory uncertainties in Ohio, with pending adult-use regulations that could impact future operations and market dynamics.
Welcome to Vext Science's fourth-quarter and fiscal year 2024 financial results conference call. As a reminder, all participants are in listen-only mode, and the conference is being recorded. (Operator Instructions)
I would now like to turn the conference over to [Priam Chakraborty].
Thanks, operator. Good morning, everyone, and thank you for joining us today. Vext fourth quarter and fiscal year 2024 financial results we released earlier this morning. The press release, financial statements and MD&A are available on SEDAR as well as on the Vext website at vextscience.com.
We would like to remind listeners that portions of today's discussion include forward-looking statements, and that forward-looking statements are included in today's filings. There can be no assurance that these forward-looking statements will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results contained therein will materialize.
Risks and uncertainties that could
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
